MAPT and Alzheimer disease: It is widely accepted that AD arises from a combination of pathological processes, including β-amyloid (Aβ) abnormality, microtubule-associated protein tau (Tau) hyperphosphorylation, neuroinflammation, neurotransmitter imbalance, and neuronal damage [2].